These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 13419001)

  • 1. Long-term dicumarol administration as a therapeutic trial in sicklemia; report of a case.
    ADELSON HT
    N Engl J Med; 1957 Feb; 256(8):353-4. PubMed ID: 13419001
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary report on long term treatment of cardiosclerosis with dicumarol.
    BENGTSEN KK; ASPENSTROM G
    Acta Med Scand; 1957 Apr; 157(3):217-22. PubMed ID: 13424130
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term treatment of angina pectoris with dicumarol.
    GABRIELSEN Z; MYHRE JR
    Circulation; 1958 Mar; 17(3):348-53. PubMed ID: 13511653
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical experiences with anticoagulants; a comparison of coumadin (warfarin) sodium and dicumarol (bishydroxycoumarin).
    NICHOLSON JH
    Angiology; 1957 Oct; 8(5):456-65. PubMed ID: 13478915
    [No Abstract]   [Full Text] [Related]  

  • 5. My early experience with bishydroxycoumarin (dicumarol).
    ALLEN EV
    Circulation; 1959 Jan; 19(1):118-21. PubMed ID: 13619031
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term red blood cell exchange can be used to successfully treat sickle cell intrahepatic cholestasis: a case report.
    Tiftik N; Altintaş E; Kiykim A; Uçbilek E; Sezgin O
    J Clin Apher; 2004; 19(1):17-9. PubMed ID: 15095397
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial.
    Wang WC; Morales KH; Scher CD; Styles L; Olivieri N; Adams R; Brambilla D;
    J Pediatr; 2005 Aug; 147(2):244-7. PubMed ID: 16126058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sickle cell anemia and hematopoietic cell transplantation: When is a pound of cure worth more than an ounce of prevention?
    Walters MC
    Pediatr Transplant; 2004 Jun; 8 Suppl 5():33-8. PubMed ID: 15125704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dicumarol in retinitis pigmentosa.
    GORDON DM; BURKE GE
    Am J Ophthalmol; 1958 May; 45(5):666-7. PubMed ID: 13533480
    [No Abstract]   [Full Text] [Related]  

  • 10. Historical notes on the early development of anticoagulant therapy with dicumarol in Sweden.
    LEHMANN J
    Circulation; 1959 Jan; 19(1):122-6. PubMed ID: 13619032
    [No Abstract]   [Full Text] [Related]  

  • 11. An effect of drugs derived from 4-hydroxycoumarins not depending on hypoprothrombinaemia.
    DERECHIN M
    Arch Int Pharmacodyn Ther; 1957 Aug; 111(3):362-5. PubMed ID: 13459521
    [No Abstract]   [Full Text] [Related]  

  • 12. On the road to gene therapy for beta-thalassemia and sickle cell anemia.
    Bank A
    Pediatr Hematol Oncol; 2008; 25(1):1-4. PubMed ID: 18231949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arterial thrombosis].
    DEUTSCH E; BENDA L; ZISCHKA W
    Bibl Cardiol; 1958; 8():37-9. PubMed ID: 13596331
    [No Abstract]   [Full Text] [Related]  

  • 14. Cryoglobulinemia; rationale and results of bishydroxycoumarin (dicumorol) therapy.
    DOMZ CA; FEIGIN EV
    AMA Arch Intern Med; 1957 Sep; 100(3):471-3. PubMed ID: 13457470
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic perspectives of sickle cell anemia].
    Beuzàrd Y
    Rev Prat; 1992 Oct; 42(15):1908-11. PubMed ID: 1362468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative clinical study of coumadin sodium and dicumarol in patients with thromboembolic diseases.
    SHAPIRO CM; LISKER R; LICHTMAN AM; JOSEPHSON AM
    Am Heart J; 1958 Jan; 55(1):66-72. PubMed ID: 13520553
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience with outpatient anticoagulant therapy.
    GRANT WG; MACMILLAN RL
    Can Med Assoc J; 1958 Mar; 78(5):317-9. PubMed ID: 13511297
    [No Abstract]   [Full Text] [Related]  

  • 18. Predicting therapeutic efficacy for sickle cell anemia.
    Noguchi CT; Rodgers GP; Serjeant G; Schechter AN
    Prog Clin Biol Res; 1987; 251():497-505. PubMed ID: 3432275
    [No Abstract]   [Full Text] [Related]  

  • 19. Transfusion of sickle cells may be a therapeutic option for patients suffering metastatic disease.
    Goldberg JS
    Med Hypotheses; 2010 Apr; 74(4):629-30. PubMed ID: 20022432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of blood viscosity in sickle cell anemia by pentoxifylline. A case report.
    Keller F; Leonhardt H
    J Med; 1979; 10(6):429-33. PubMed ID: 299452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.